Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-07
2009-06-30
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S305000, C546S133000, C546S183000
Reexamination Certificate
active
07553846
ABSTRACT:
Compounds of formulae I and II:are disclosed as 5-HT3inhibitors. Those compounds are useful in treating CINV, IBS-D and other diseases and conditions.
REFERENCES:
patent: 5260303 (1993-11-01), Becker et al.
patent: 5631257 (1997-05-01), Iwamatsu et al.
patent: 6353010 (2002-03-01), Dyke et al.
patent: 0621271 (1994-10-01), None
patent: 0975327 (2000-02-01), None
patent: WO2003037896 (2003-05-01), None
patent: WO2006089100 (2006-08-01), None
PCT International Search Report for PCT/US2007/075355 dated Feb. 7, 2008.
PCT International Search Report for PCT/US2007/075378 dated Feb. 26, 2008.
Manning David D.
Yang Zhicai
Albany Molecular Research, Inc.
Heslin Rothenberg Farley & & Mesiti P.C.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
2-alkylbenzoxazole carboxamides as 5-HT 3 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-alkylbenzoxazole carboxamides as 5-HT 3 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-alkylbenzoxazole carboxamides as 5-HT 3 modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4102239